Growth Metrics

Galectin Therapeutics (GALT) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 20.11%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 14.71%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 31.42%
10 Galectin Therapeutics 165.77 Mn 151.67 Mn - 28.98%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 28.98%
Dec 31, 2025 5.55%
Sep 30, 2025 25.15%
Jun 30, 2025 3.81%
Mar 31, 2025 1.49%
Dec 31, 2024 -22.47%
Sep 30, 2024 -19.65%
Jun 30, 2024 -11.71%
Mar 31, 2024 -23.79%
Dec 31, 2023 4.36%
Sep 30, 2023 2.39%
Jun 30, 2023 -55.72%
Mar 31, 2023 -35.16%
Dec 31, 2022 -24.41%
Sep 30, 2022 -78.20%
Jun 30, 2022 -47.18%
Mar 31, 2022 -34.79%
Dec 31, 2021 -51.30%
Sep 30, 2021 -46.89%
Jun 30, 2021 -24.75%
Mar 31, 2021 -21.98%
Dec 31, 2020 -11.52%
Sep 30, 2020 -38.03%
Jun 30, 2020 19.55%
Mar 31, 2020 -4.20%
Dec 31, 2019 8.24%
Sep 30, 2019 24.62%
Jun 30, 2019 20.34%
Mar 31, 2019 2.01%
Dec 31, 2018 24.16%
Sep 30, 2018 32.31%
Jun 30, 2018 -1.02%
Mar 31, 2018 6.57%
Dec 31, 2017 -7.84%
Sep 30, 2017 1.64%
Jun 30, 2017 -27.52%
Mar 31, 2017 -2.20%
Dec 31, 2016 -43.51%
Sep 30, 2016 -32.43%
Jun 30, 2016 -33.63%
Mar 31, 2016 -12.93%
Dec 31, 2015 -37.91%
Sep 30, 2015 -34.73%
Jun 30, 2015 -11.00%
Mar 31, 2015 -42.62%
Dec 31, 2014 -26.39%
Sep 30, 2014 -37.92%
Jun 30, 2014 -16.74%
Mar 31, 2014 -38.34%
Dec 31, 2013 -41.34%
Sep 30, 2013 -21.49%